Reduction of fibroproliferative changes in irradiated rat lung with soluble transforming growth factor-β receptor.

Mol Med Rep

Department of Biochemistry and Molecular Pathophysiology, University of Occupational and Environmental Health, School of Medicine, Kitakyusyu, Fukuoka 807-8556, Japan.

Published: April 2015

The present study investigated whether established fibroproliferative changes in the irradiated rat lung are histopathologically reduced by an adenovirus‑mediated soluble transforming growth factor (TGF)‑β type II receptor. Replication‑defective adenoviral vectors expressing a type II human TGF‑β receptor (AdTβ‑ExR) were prepared. Male Fisher‑344 rats were divided into the C, R and R + T groups. The rats in the C group did not receive irradiation or treatment. The rats in the R and R + T group each received 30 Gy irradiation to the right lung. Eight weeks following irradiation, the rats in the R and R + T group were treated with saline or AdTβ‑ExR, respectively. To analyze the TGF‑β expression, myofibroblast proliferation and macrophage/monocyte infiltration, sections of the lung were immunohistochemically stained at 16 weeks following irradiation. Silver staining was performed for semi‑quantitative evaluation of the fibroproliferative changes. Definitive TGF‑β expression, myofibroblast proliferation and macrophage/monocyte infiltration were observed in the lungs of the R group, but were significantly lower in the lungs of the R + T group. With respect to the fibroproliferative changes, the proportion of red‑stained areas in the R + T group was markedly lower than that in the R group. These data indicate that fibroproliferative changes induced by radiation are reversible and that TGF‑β has a critical role in fibroproliferative changes in the irradiated lung. The present results suggest that gene therapy with an adenoviral vector expressing a soluble TGF‑β receptor may be effective in reducing the established pulmonary fibrosis caused by radiation.

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2014.3064DOI Listing

Publication Analysis

Top Keywords

fibroproliferative changes
24
changes irradiated
12
rats group
12
irradiated rat
8
rat lung
8
soluble transforming
8
transforming growth
8
tgf‑β receptor
8
weeks irradiation
8
tgf‑β expression
8

Similar Publications

Keloid scarring is a fibroproliferative disease of the skin, which can significantly impact one's quality of life through cosmetic concerns, physical discomfort (itchy; painful), restricted movement, and psychological distress. Owing to the poorly understood pathogenesis of keloids and their high recurrence rate, the efficacy of keloid treatment remains unsatisfactory, particularly in patients susceptible to multiple keloids. We conducted fecal metagenomic analyzes and both untargeted and targeted plasma metabolomics in patients with multiple keloids (MK,  = 56) and controls with normal scars (NS,  = 60); tissue-untargeted metabolomics (MK,  = 35; NS,  = 32), tissue-targeted metabolomics (MK,  = 41; NS,  = 36), and single-cell sequencing analyzes (GSE163973).

View Article and Find Full Text PDF

Fibroproliferative remodeling of distal pulmonary arterioles is a cornerstone characteristic of pulmonary arterial hypertension (PAH). Data from contemporary quantitative imaging suggest that anabolic synthesis of macromolecular substrate, defined here as , is the proximate event that causes vascular remodeling via pathogenic changes to DNA, collagen, cytoskeleton, and lipid membranes. Modifying biomass is achievable but requires tilting the balance in favor of endogenous degradation over synthetic pathways in order to advance the first-ever disease-modifying PAH pharmacotherapy.

View Article and Find Full Text PDF

A review of Peyronie's disease insurance coverage.

Sex Med

October 2024

Division of Plastic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, United States.

Article Synopsis
  • Peyronie's disease (PD) leads to penile curvature and related issues, with various treatment options available including surgery, devices, and medications.
  • A study examined insurance coverage for these treatments across top US insurers, finding only 54% had clear policies on PD.
  • The most commonly covered treatment was collagenase injections, while shock wave therapy was universally denied, highlighting significant gaps in coverage and suggesting a need for better alignment with clinical guidelines.
View Article and Find Full Text PDF
Article Synopsis
  • Dupuytren's disease (DD) is a disorder affecting the connective tissue in the hand, with unclear causes, and studies indicate that WNT4, a part of WNT signaling, may play a role in the disease.
  • The research involved isolating fibroblasts from both healthy individuals and those with DD in a family setting, using WNT4 siRNA to analyze gene expression changes through RNA sequencing.
  • Findings revealed that normal fibroblasts showed significant changes towards a 'DD-like' state when WNT4 was downregulated, suggesting that loss of WNT4 expression is a critical factor in the onset of Dupuytren's disease.
View Article and Find Full Text PDF

Importance: Current medical therapies in idiopathic subglottic stenosis (iSGS) are insufficient in preventing the development and progression of scar tissue. An inhibitor of mammalian target of rapamycin, everolimus is an immunosuppressive medication shown to be effective in reducing fibrosis across a variety of fibroproliferative disorders, including preclinical models of iSGS.

Objective: To evaluate the effect of oral everolimus on postoperative recurrence of stenosis in iSGS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!